Mashkani B, Griffith R, Ashman L. Differences in growth promotion, drug response and intracellular protein trafficking of FLT3 mutants. Iran J Basic Med Sci. 2014;17:867-73 pubmed

Goemans B, Zwaan C, Cloos J, de Lange D, Loonen A, Reinhardt D, et al. FLT3 and KIT mutated pediatric acute myeloid leukemia (AML) samples are sensitive in vitro to the tyrosine kinase inhibitor SU11657. Leuk Res. 2010;34:1302-7 pubmed publisher

Schmidt Arras D, Böhmer S, Koch S, Müller J, Blei L, Cornils H, et al. Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality. Blood. 2009;113:3568-76 pubmed publisher